The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

Postpartum diabetes risk was elevated among women with a history of gestational diabetes and a high-stable or inverse U-shaped BMI trajectory.

During pregnancy, women should receive recommended COVID-19 vaccines to protect themselves, as well as their young infants.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Influenza-related hospitalization rates in the US varied significantly from 2010/2011 through the 2022/2023, an MMWR report found.

Compared to DNA sequencing alone, concurrent DNA and RNA sequencing revealed more clinically actionable variants in NSCLC.

Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.

In IPF, antifibrotic therapy discontinuation was linked to patient variables that included depression, lower DLCO, and higher all-cause mortality.

Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.

Povidone-iodine vs chlorohexidine gluconate demonstrated a reduction in deep SSI, but an increased risk for overall and superficial SSI.